Carregant...
Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort
BACKGROUND: Bimagrumab prevents activity of myostatin and other negative regulators of skeletal muscle mass. This randomized double‐blind, placebo‐controlled study investigated safety, pharmacokinetics (PK), and pharmacodynamics of bimagrumab in healthy older and obese adults. METHODS: A cohort of o...
Guardat en:
| Publicat a: | J Cachexia Sarcopenia Muscle |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7749589/ https://ncbi.nlm.nih.gov/pubmed/33264516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12639 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|